Physician

Andrew Bennett Brown, M.D.

According to 2025 Medicare claims, Andrew Brown, M.D. (NPI: 1386800464) practices hematology/oncology in the Newark, NJ market, with the plurality of this provider's patient population coming from Essex, NJ. This provider's primary affiliated billing organization is BARNABAS HEALTH MEDICAL GROUP PC (NPI: 1841557246; TIN: 454832340) and primary practice location at 07039-5672. Brown is affiliated with the RWJBH Accountable Care, LLC (ACO ID: A1247), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Brown's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 316 traditional Medicare patients, billed 1,243 HCPCS/CPT codes, and received $119,264 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,241 prescription claims across 270 beneficiaries totaling $2,942,898 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 78 claims. Open Payments data shows 12 records totaling $290. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $221,728 to $2,942,898. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$60K$119K2015 Medicare payment: $76,036 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $79,265 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $65,476 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $74,185 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $60,980 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $47,188 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $54,558 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $54,578 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $73,527 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $119,264 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153131,074$76,036
20163441,153$79,265
20173521,068$65,476
20184011,141$74,185
2019331963$60,980
2020253694$47,188
2021265642$54,558
2022270672$54,578
2023296843$73,527
20243161,243$119,264

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$2.9M2015 Drug cost: $221,728 (USD; Tot_Drug_Cst)2016 Drug cost: $288,514 (USD; Tot_Drug_Cst)2017 Drug cost: $336,707 (USD; Tot_Drug_Cst)2018 Drug cost: $559,842 (USD; Tot_Drug_Cst)2019 Drug cost: $780,819 (USD; Tot_Drug_Cst)2020 Drug cost: $1,127,828 (USD; Tot_Drug_Cst)2021 Drug cost: $1,432,967 (USD; Tot_Drug_Cst)2022 Drug cost: $1,432,348 (USD; Tot_Drug_Cst)2023 Drug cost: $2,197,359 (USD; Tot_Drug_Cst)2024 Drug cost: $2,942,898 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151951,159$221,728
20162311,395$288,514
20172481,380$336,707
20182501,414$559,842
20192291,059$780,819
2020197875$1,127,828
2021169772$1,432,967
2022170854$1,432,348
2023189822$2,197,359
20242701,241$2,942,898

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$14K$27K2015 Medicare payment: $27,364 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $12,920 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $188 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,156 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,302 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R42$27,364
2016N/R32$12,920
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R15$188
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R32$1,156
2023N/RN/RN/R
2024N/R78$2,302

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more3939$144
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more94583$113
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes7082$106
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more209417$73
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes5188$63

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TagrissoOsimertinib Mesylate421,260$694,274
IbrancePalbociclib29794$437,714
VerzenioAbemaciclib17476$273,371
BesremiRopeginterferon Alfa-2b-Njft13364$219,645
LonsurfTrifluridine/Tipiracil Hcl12336$123,201

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R27$1,238
E1392Portable oxygen concentrator, rentalYN/R12$405
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R21$395
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R18$263

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$176SUN PHARMACEUTICAL INDUSTRIES INC.
Research PaymentsReported research-related payment or transfer-of-value amount.1$114Cooperman Barnabas Medical Center
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew Bennett Brown, M.D.?

Tedicare shows public-source Medicare data for Andrew Bennett Brown, M.D. (NPI 1386800464), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Bennett Brown, M.D. have ACO affiliation data?

Andrew Bennett Brown, M.D. is shown with ACO affiliation data for RWJBH Accountable Care, LLC (MSSP, ACO ID A1247), Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Andrew Bennett Brown, M.D.?

Andrew Bennett Brown, M.D. is linked to BARNABAS HEALTH MEDICAL GROUP PC (billing NPI 1841557246) in the available physician profile data.

Does Andrew Bennett Brown, M.D. have Open Payments data?

Andrew Bennett Brown, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.